AI assistant
Sending…
Avidity Biosciences, Inc. — Director's Dealing 2024
Aug 5, 2024
30894_dirs_2024-08-05_daab47c5-f640-4e9a-9665-0b76bb6d0eb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2024-08-01
Reporting Person: Moriarty John B (Chief Legal Officer)
More from Avidity Biosciences, Inc.
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27